anti il 17a monoclonal antibody Search Results


93
Boster Bio anti il 17a primary antibody
Anti Il 17a Primary Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+il+17a+monoclonal+antibody/Anti-IL-17A+Monoclonal+Antibody/pm41923122-152-10-13
Average 93 stars, based on 1 article reviews
anti il 17a primary antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

91
Boster Bio anti mouse il 17a antibody
Fig. 3 Pirfenidone inhibited the secretion of <t>IL-17A</t> in early-stage silicosis models. ELISA was used to detect the protein levels of IL-17A in serum (a) and BALF (b). The mRNA and protein levels of IL-17A in lung tissues from different groups were measured by qPCR (c), immunohistochemistry (d), and Western blot analysis (e). All data were presented as mean ± SD; n = 10 for each group; ***P < 0.001, ****P < 0.0001, ns (no statistical significance).
Anti Mouse Il 17a Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+il+17a+monoclonal+antibody/Anti-Mouse+IL-17A+Monoclonal+Antibody/pm34316030-65-8-12
Average 91 stars, based on 1 article reviews
anti mouse il 17a antibody - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

92
Kingfisher Biotech il 17a capture mab
Cellular immune responses in the airways and peripheral blood of BCG-vaccinated calves. ( A ) Peripheral blood was collected 4-, 8-, 12- and 16-weeks after vaccination from control (n = 7) or BCG–vaccinated animals (n = 7). PBMC were isolated and stimulated for 6 days with PPD-b. Control wells remained unstimulated. ( B ) BAL were collected at 4-, 12- and 16-weeks after vaccination. BAL cells were stimulated for 72 hours in vitro with PPD-b. Control wells remained unstimulated. Cell culture supernatants were collected from BAL and PBMC cultures and analyzed by commercial ELISA kit for IFNγ (upper panel) <t>and</t> <t>IL-17</t> (lower panel). Data represent means ± SEM. *p < 0.05, **p < 0.01 ***p < 0.001 as determined by Student’s t test. This figure was previously published and is duplicated with permission.
Il 17a Capture Mab, supplied by Kingfisher Biotech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+il+17a+monoclonal+antibody/Anti-bovine+IL-17A+monoclonal+antibody/pmc06831659-278-18-23
Average 92 stars, based on 1 article reviews
il 17a capture mab - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
Covalab Inc monoclonal rat anti-mouse il-17a antibody
Treatment with hyaluronan oligosaccharides (oligo-HAs) reduced inflammatory cell infiltration, interleukin-17 (IL-17), and kallikrein 5 (KLK5) expressions. (A) Hematoxylin and eosin-stained tissue sections of LL-37 induced rosacea-like mice showed marked inflammatory cellular infiltration. Further treatments with oligo-HAs reduced cellular infiltration (H&E, ×100). (B) Majority of infiltrated cells were CD4+ T cells and infiltration of CD4+ T cells decreased in oligo-HAs treated group (CD4, ×100). (C) <t>IL-17A</t> expression was markedly increased in the epidermis of LL-37 induced rosacea-like mice. Oligo-HAs decreased the IL-17A expression regardless of the injection method (IL-17A, ×200). (D) Expression of KLK5 was increased in LL-37 induced rosacea-like mice (arrow head). Further treatment with oligo-HAs reduced KLK5 expression (KLK5, ×400). i.d.: intradermally, i.p.: intraperitoneally.
Monoclonal Rat Anti Mouse Il 17a Antibody, supplied by Covalab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+il+17a+monoclonal+antibody/monoclonal+rat+anti+mouse+il+17a+antibody/pmc07992622-56-27-32
Average 90 stars, based on 1 article reviews
monoclonal rat anti-mouse il-17a antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier








Image Search Results


Fig. 3 Pirfenidone inhibited the secretion of IL-17A in early-stage silicosis models. ELISA was used to detect the protein levels of IL-17A in serum (a) and BALF (b). The mRNA and protein levels of IL-17A in lung tissues from different groups were measured by qPCR (c), immunohistochemistry (d), and Western blot analysis (e). All data were presented as mean ± SD; n = 10 for each group; ***P < 0.001, ****P < 0.0001, ns (no statistical significance).

Journal: Acta pharmacologica Sinica

Article Title: Pirfenidone ameliorates silica-induced lung inflammation and fibrosis in mice by inhibiting the secretion of interleukin-17A.

doi: 10.1038/s41401-021-00706-4

Figure Lengend Snippet: Fig. 3 Pirfenidone inhibited the secretion of IL-17A in early-stage silicosis models. ELISA was used to detect the protein levels of IL-17A in serum (a) and BALF (b). The mRNA and protein levels of IL-17A in lung tissues from different groups were measured by qPCR (c), immunohistochemistry (d), and Western blot analysis (e). All data were presented as mean ± SD; n = 10 for each group; ***P < 0.001, ****P < 0.0001, ns (no statistical significance).

Article Snippet: IL-17A neutralization By intraperitoneal injection, 100 μg of anti-mouse IL-17A antibody (M00421-2, BOSTER, Wuhan, China) or isotype control IgG (ab18443, abcam, Cambridge, UK) was given to silica-exposed mice weekly for 4 weeks, starting 1 day after silica exposure.

Techniques: Enzyme-linked Immunosorbent Assay, Immunohistochemistry, Western Blot

Fig. 6 Pirfenidone diminished the production of IL-17A in advanced silicosis models. ELISA was performed to measure the protein expression of IL-17A in serum (a) and BALF (b) from different groups. The mRNA and protein levels of IL-17A in lung tissues were measured by qPCR (c), immunohistochemistry (d) and Western blot analysis (e), respectively. All data were presented as mean ± SD; n = 10 for each group; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Journal: Acta pharmacologica Sinica

Article Title: Pirfenidone ameliorates silica-induced lung inflammation and fibrosis in mice by inhibiting the secretion of interleukin-17A.

doi: 10.1038/s41401-021-00706-4

Figure Lengend Snippet: Fig. 6 Pirfenidone diminished the production of IL-17A in advanced silicosis models. ELISA was performed to measure the protein expression of IL-17A in serum (a) and BALF (b) from different groups. The mRNA and protein levels of IL-17A in lung tissues were measured by qPCR (c), immunohistochemistry (d) and Western blot analysis (e), respectively. All data were presented as mean ± SD; n = 10 for each group; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Article Snippet: IL-17A neutralization By intraperitoneal injection, 100 μg of anti-mouse IL-17A antibody (M00421-2, BOSTER, Wuhan, China) or isotype control IgG (ab18443, abcam, Cambridge, UK) was given to silica-exposed mice weekly for 4 weeks, starting 1 day after silica exposure.

Techniques: Enzyme-linked Immunosorbent Assay, Expressing, Immunohistochemistry, Western Blot

Cellular immune responses in the airways and peripheral blood of BCG-vaccinated calves. ( A ) Peripheral blood was collected 4-, 8-, 12- and 16-weeks after vaccination from control (n = 7) or BCG–vaccinated animals (n = 7). PBMC were isolated and stimulated for 6 days with PPD-b. Control wells remained unstimulated. ( B ) BAL were collected at 4-, 12- and 16-weeks after vaccination. BAL cells were stimulated for 72 hours in vitro with PPD-b. Control wells remained unstimulated. Cell culture supernatants were collected from BAL and PBMC cultures and analyzed by commercial ELISA kit for IFNγ (upper panel) and IL-17 (lower panel). Data represent means ± SEM. *p < 0.05, **p < 0.01 ***p < 0.001 as determined by Student’s t test. This figure was previously published and is duplicated with permission.

Journal: Scientific Reports

Article Title: Characterization of local and circulating bovine γδ T cell responses to respiratory BCG vaccination

doi: 10.1038/s41598-019-52565-z

Figure Lengend Snippet: Cellular immune responses in the airways and peripheral blood of BCG-vaccinated calves. ( A ) Peripheral blood was collected 4-, 8-, 12- and 16-weeks after vaccination from control (n = 7) or BCG–vaccinated animals (n = 7). PBMC were isolated and stimulated for 6 days with PPD-b. Control wells remained unstimulated. ( B ) BAL were collected at 4-, 12- and 16-weeks after vaccination. BAL cells were stimulated for 72 hours in vitro with PPD-b. Control wells remained unstimulated. Cell culture supernatants were collected from BAL and PBMC cultures and analyzed by commercial ELISA kit for IFNγ (upper panel) and IL-17 (lower panel). Data represent means ± SEM. *p < 0.05, **p < 0.01 ***p < 0.001 as determined by Student’s t test. This figure was previously published and is duplicated with permission.

Article Snippet: Briefly, 96-well ELISPOT plates (Millipore) were coated at 4 °C overnight with an anti-bovine IFNγ capture mAb or IL-17A capture mAb (both from Kingfisher Biotech, Inc., St. Paul, MN), followed by a blocking step in cRPMI, for 2 h at 37 °C, 5% CO 2 .

Techniques: Control, Isolation, In Vitro, Cell Culture, Enzyme-linked Immunosorbent Assay

Cellular immune responses in lung-draining lymph nodes of BCG-vaccinated calves. Lung-draining tracheobronchial ( A ) and mediastinal lymph nodes ( B ), were collected from control (n = 7) or BCG–vaccinated animals (n = 7) during necropsy at 16 weeks after vaccination. Cells were isolated as described in Materials & Methods and restimulated for 6 days with PPD-b. Control wells remained unstimulated. Cell culture supernatants were collected from cultures and analyzed by commercial ELISA kit for IFNγ (upper panel) and IL-17 (lower panel). Data represent means ± SEM. **p < 0.01 ***p < 0.001 ****p < 0.001 as determined by Student’s t test. This figure was previously published and is duplicated with permission.

Journal: Scientific Reports

Article Title: Characterization of local and circulating bovine γδ T cell responses to respiratory BCG vaccination

doi: 10.1038/s41598-019-52565-z

Figure Lengend Snippet: Cellular immune responses in lung-draining lymph nodes of BCG-vaccinated calves. Lung-draining tracheobronchial ( A ) and mediastinal lymph nodes ( B ), were collected from control (n = 7) or BCG–vaccinated animals (n = 7) during necropsy at 16 weeks after vaccination. Cells were isolated as described in Materials & Methods and restimulated for 6 days with PPD-b. Control wells remained unstimulated. Cell culture supernatants were collected from cultures and analyzed by commercial ELISA kit for IFNγ (upper panel) and IL-17 (lower panel). Data represent means ± SEM. **p < 0.01 ***p < 0.001 ****p < 0.001 as determined by Student’s t test. This figure was previously published and is duplicated with permission.

Article Snippet: Briefly, 96-well ELISPOT plates (Millipore) were coated at 4 °C overnight with an anti-bovine IFNγ capture mAb or IL-17A capture mAb (both from Kingfisher Biotech, Inc., St. Paul, MN), followed by a blocking step in cRPMI, for 2 h at 37 °C, 5% CO 2 .

Techniques: Control, Isolation, Cell Culture, Enzyme-linked Immunosorbent Assay

Long-term cultured and ex vivo IFNγ responses by cattle after M. bovis aerosol vaccination. Cultured ELISPOT analysis was performed ~8 weeks after BCG aerosol vaccination. ( A ) For the ex vivo response, freshly isolated PBMCs were stimulated with rTb10.4/Ag85a or PPD-b or medium alone for 20 h (IFNγ) or for 48 hours (IL-17A). (B) Long-term cultured cells were generated by stimulating PBMC with a cocktail of rTB10.4/rAg85A (1 μg/ml each) and PPD-b (200 IU/ml) for 13 days followed by transfer to ELISPOT plates with APCs and the addition of either rTb10.4/Ag85a, PPD-b or medium alone. Medium control responses were subtracted from antigen-stimulated responses and results are presented as mean spot forming cells (SFC)/10 6 cells ( ± SEM) for ( A ) ex vivo conditions or ( B) long-term culture *p < 0.05 **p < 0.01 ***p < 0.001 as determined by Student’s t test. This figure was previously published and is duplicated with permission.

Journal: Scientific Reports

Article Title: Characterization of local and circulating bovine γδ T cell responses to respiratory BCG vaccination

doi: 10.1038/s41598-019-52565-z

Figure Lengend Snippet: Long-term cultured and ex vivo IFNγ responses by cattle after M. bovis aerosol vaccination. Cultured ELISPOT analysis was performed ~8 weeks after BCG aerosol vaccination. ( A ) For the ex vivo response, freshly isolated PBMCs were stimulated with rTb10.4/Ag85a or PPD-b or medium alone for 20 h (IFNγ) or for 48 hours (IL-17A). (B) Long-term cultured cells were generated by stimulating PBMC with a cocktail of rTB10.4/rAg85A (1 μg/ml each) and PPD-b (200 IU/ml) for 13 days followed by transfer to ELISPOT plates with APCs and the addition of either rTb10.4/Ag85a, PPD-b or medium alone. Medium control responses were subtracted from antigen-stimulated responses and results are presented as mean spot forming cells (SFC)/10 6 cells ( ± SEM) for ( A ) ex vivo conditions or ( B) long-term culture *p < 0.05 **p < 0.01 ***p < 0.001 as determined by Student’s t test. This figure was previously published and is duplicated with permission.

Article Snippet: Briefly, 96-well ELISPOT plates (Millipore) were coated at 4 °C overnight with an anti-bovine IFNγ capture mAb or IL-17A capture mAb (both from Kingfisher Biotech, Inc., St. Paul, MN), followed by a blocking step in cRPMI, for 2 h at 37 °C, 5% CO 2 .

Techniques: Cell Culture, Ex Vivo, Aerosol, Enzyme-linked Immunospot, Isolation, Generated, Control

Treatment with hyaluronan oligosaccharides (oligo-HAs) reduced inflammatory cell infiltration, interleukin-17 (IL-17), and kallikrein 5 (KLK5) expressions. (A) Hematoxylin and eosin-stained tissue sections of LL-37 induced rosacea-like mice showed marked inflammatory cellular infiltration. Further treatments with oligo-HAs reduced cellular infiltration (H&E, ×100). (B) Majority of infiltrated cells were CD4+ T cells and infiltration of CD4+ T cells decreased in oligo-HAs treated group (CD4, ×100). (C) IL-17A expression was markedly increased in the epidermis of LL-37 induced rosacea-like mice. Oligo-HAs decreased the IL-17A expression regardless of the injection method (IL-17A, ×200). (D) Expression of KLK5 was increased in LL-37 induced rosacea-like mice (arrow head). Further treatment with oligo-HAs reduced KLK5 expression (KLK5, ×400). i.d.: intradermally, i.p.: intraperitoneally.

Journal: Annals of Dermatology

Article Title: Hyaluronan Oligosaccharides Improve Rosacea-Like Phenotype through Anti-Inflammatory and Epidermal Barrier-Improving Effects

doi: 10.5021/ad.2020.32.3.189

Figure Lengend Snippet: Treatment with hyaluronan oligosaccharides (oligo-HAs) reduced inflammatory cell infiltration, interleukin-17 (IL-17), and kallikrein 5 (KLK5) expressions. (A) Hematoxylin and eosin-stained tissue sections of LL-37 induced rosacea-like mice showed marked inflammatory cellular infiltration. Further treatments with oligo-HAs reduced cellular infiltration (H&E, ×100). (B) Majority of infiltrated cells were CD4+ T cells and infiltration of CD4+ T cells decreased in oligo-HAs treated group (CD4, ×100). (C) IL-17A expression was markedly increased in the epidermis of LL-37 induced rosacea-like mice. Oligo-HAs decreased the IL-17A expression regardless of the injection method (IL-17A, ×200). (D) Expression of KLK5 was increased in LL-37 induced rosacea-like mice (arrow head). Further treatment with oligo-HAs reduced KLK5 expression (KLK5, ×400). i.d.: intradermally, i.p.: intraperitoneally.

Article Snippet: To detect CD4, IL-17A, KLK5, filaggrin, and CD44 in histological specimens from mice, primary antibodies including a monoclonal mouse anti-CD4 antibody (BD Biosciences, Franklin Lakes, NJ, USA), monoclonal rat anti-mouse IL-17A antibody (Covalab, Villeurbanne, France), polyclonal rabbit anti-KLK5 antibody (Abcam, Cambridge, UK), polyclonal mouse anti-profilaggrin antibody (Covance, Princeton, NJ, USA), and monoclonal rat anti-human/mice CD44 antibody (eBioscience, San Diego, CA, USA) were used.

Techniques: Staining, Expressing, Injection